Elon Musk's brain-implant company Neuralink on Thursday said it had received FDA approval to launch first-in-human clinical study.
REUTERS
REUTERS
Reuters
Elon Musk's Neuralink wins FDA approval for human study of brain implants
Elon Musk's Neuralink received U.S. Food and Drug Administration (FDA) clearance for its first-in-human clinical trial, a critical milestone for the brain-implant startup as it faces U.S. probes over its handling of animal experiments.